Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Kingfa Science
Quarter-by-quarter operating performance
| Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 340 | 366 | 339 | 351 | 394 | 404 | 416 | 418 | 440 | 470 | 462 | 466 | 489 |
| Expenses + | 310 | 311 | 289 | 306 | 356 | 354 | 359 | 362 | 389 | 409 | 404 | 405 | 428 |
| Operating Profit | 31 | 55 | 50 | 45 | 38 | 51 | 57 | 56 | 51 | 60 | 58 | 61 | 62 |
| OPM % | 9% | 15% | 15% | 13% | 10% | 13% | 14% | 13% | 12% | 13% | 13% | 13% | 13% |
| Other Income + | 1 | 1 | 2 | 0 | 1 | 2 | 2 | 1 | 5 | 2 | 4 | 3 | 7 |
| Interest | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| Depreciation | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 7 | 7 |
| Profit before tax | 27 | 49 | 47 | 40 | 32 | 45 | 52 | 50 | 49 | 54 | 54 | 55 | 61 |
| Tax % | 25% | 26% | 25% | 25% | 25% | 26% | 25% | 26% | 30% | 23% | 26% | 26% | 26% |
| Net Profit + | 20 | 37 | 35 | 30 | 24 | 34 | 39 | 37 | 35 | 42 | 40 | 41 | 45 |
| EPS in Rs | 16.70 | 30.24 | 28.93 | 24.44 | 20.09 | 27.70 | 32.26 | 30.77 | 28.60 | 34.60 | 32.86 | 30.36 | 33.33 |
Financials of Kingfa Science
Annual income statement trend
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 178 | 219 | 314 | 427 | 602 | 702 | 742 | 627 | 1,048 | 1,404 | 1,488 | 1,745 | 1,887 |
| Expenses + | 181 | 212 | 288 | 408 | 560 | 666 | 698 | 607 | 966 | 1,276 | 1,303 | 1,520 | 1,646 |
| Operating Profit | -3 | 6 | 27 | 19 | 41 | 35 | 43 | 20 | 82 | 128 | 185 | 225 | 241 |
| OPM % | -2% | 3% | 8% | 5% | 7% | 5% | 6% | 3% | 8% | 9% | 12% | 13% | 13% |
| Other Income + | 0 | 0 | 1 | 4 | 6 | 4 | 3 | 6 | -22 | 2 | 3 | 9 | 15 |
| Interest | 7 | 8 | 7 | 2 | 2 | 2 | 4 | 3 | 5 | 7 | 6 | 7 | 5 |
| Depreciation | 3 | 3 | 3 | 3 | 6 | 8 | 9 | 11 | 13 | 14 | 18 | 22 | 26 |
| Profit before tax | -12 | -5 | 17 | 18 | 39 | 29 | 33 | 12 | 41 | 110 | 164 | 206 | 224 |
| Tax % | -31% | -35% | 38% | 30% | 36% | 35% | 26% | 55% | 26% | 26% | 25% | 26% | |
| Net Profit + | -8 | -3 | 11 | 12 | 25 | 19 | 25 | 5 | 31 | 81 | 123 | 153 | 168 |
| EPS in Rs | -6.95 | -2.49 | 8.93 | 10.24 | 20.35 | 15.74 | 20.33 | 4.39 | 25.29 | 67.22 | 101.17 | 126.22 | 131.15 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 10% | 0% |
Financials of Kingfa Science
Capital structure and asset base
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 10 | 10 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 14 |
| Reserves | 5 | 2 | 109 | 234 | 293 | 312 | 336 | 342 | 372 | 454 | 576 | 716 | 1,281 |
| Borrowings + | 62 | 75 | 16 | 42 | 21 | 17 | 46 | 71 | 46 | 42 | 33 | 43 | 19 |
| Other Liabilities + | 31 | 41 | 95 | 119 | 159 | 210 | 202 | 246 | 449 | 502 | 373 | 384 | 421 |
| Total Liabilities | 105 | 125 | 230 | 405 | 485 | 551 | 596 | 671 | 880 | 1,010 | 994 | 1,156 | 1,735 |
| Fixed Assets + | 24 | 25 | 29 | 76 | 88 | 85 | 107 | 129 | 126 | 123 | 252 | 244 | 290 |
| CWIP | 0 | 1 | 41 | 10 | 2 | 79 | 115 | 123 | 127 | 131 | 2 | 41 | 45 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 81 | 99 | 160 | 319 | 395 | 388 | 375 | 419 | 627 | 756 | 740 | 871 | 1,399 |
| Total Assets | 105 | 125 | 230 | 405 | 485 | 551 | 596 | 671 | 880 | 1,010 | 994 | 1,156 | 1,735 |
Financials of Kingfa Science
Operating, investing and financing cash movement
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | -24 | -1 | 19 | -119 | -116 | 96 | 30 | -2 | 38 | 27 | 16 | 60 |
| Cash from Investing Activity + | -1 | -4 | -47 | -18 | -6 | -77 | -63 | -14 | -19 | -12 | 2 | -30 |
| Cash from Financing Activity + | 25 | 5 | 34 | 137 | 14 | -7 | 22 | 17 | -14 | -21 | -8 | -7 |
| Net Cash Flow | 0 | 0 | 6 | -1 | -108 | 12 | -11 | 1 | 5 | -6 | 10 | 23 |
| Free Cash Flow | -26 | -5 | -28 | -138 | -127 | 14 | -35 | -17 | 19 | 3 | -5 | 30 |
| CFO/OP | 741% | -13% | 72% | -602% | -256% | 300% | 111% | 5% | 63% | 35% | 29% | 56% |
Financials of Kingfa Science
Working capital efficiency and return ratios
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 97 | 93 | 99 | 111 | 110 | 109 | 97 | 123 | 99 | 93 | 99 | 93 |
| Inventory Days | 54 | 64 | 85 | 69 | 85 | 63 | 67 | 100 | 110 | 94 | 76 | 82 |
| Days Payable | 66 | 72 | 127 | 108 | 108 | 119 | 115 | 152 | 181 | 155 | 110 | 94 |
| Cash Conversion Cycle | 85 | 85 | 57 | 72 | 86 | 53 | 49 | 71 | 28 | 32 | 66 | 80 |
| Working Capital Days | -7 | -14 | 66 | 59 | 96 | 59 | 55 | 57 | 39 | 45 | 78 | 85 |
| ROCE % | -9% | 4% | 22% | 9% | 13% | 9% | 10% | 4% | 16% | 25% | 30% | 31% |
PAT growth seen with recent quarters growing by ~85% YoY, indicating strong earnings momentum. Key concall takeaways from Rathi Steel & Power Ltd's Q1 FY27…
SKP is steadily increasing capacity from about 80-100 tons earlier to around 1,800 tons now, operating at ~80% utilization (Page 20). Key concall takeaways…
Q1 FY27 showed strong profitability with EBITDA margin improving to 16.29% and net profit margin to 9.18%. Key concall takeaways from Mitsu Chem Plast Ltd's Q1…
Current capacity expansion planned for 300-350 crores revenue, further growth through organic or inorganic expansion. Key concall takeaways from Simplex…